TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
ADDvance Pharma in Scandinavia AB
Closing information (x1000 EUR)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
1,704
|
1,272 | |
| Financial expenses |
0
|
8 | |
| Earnings before taxes |
353
|
140 | |
| EBITDA |
339
|
148 | |
| Total assets |
970
|
759 | |
| Current assets |
780
|
692 | |
| Current liabilities |
442
|
260 | |
| Equity capital |
485
|
452 | |
| - share capital |
8
|
9 | |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
50.0%
|
59.6% | |
| Turnover per employee |
852
|
636 | |
| Profit as a percentage of turnover |
20.7%
|
11.0% | |
| Return on assets (ROA) |
36.4%
|
19.5% | |
| Current ratio |
176.5%
|
266.2% | |
| Return on equity (ROE) |
72.8%
|
31.0% | |
| Change turnover |
557
|
38 | |
| Change turnover % |
3%
|
49%
|
3% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.